Related Experiment Video
Updated: Nov 17, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study
Jaime Lora-Tamayo1, Guillermo Maestro1, Antonio Lalueza1
1Internal Medicine Department, 12 de Octubre University Hospital, Research Institute Hospital 12 de Octubre "i+12 Institute", Madrid, Spain.
No abstract available in PubMed .
Related Concept Videos
Retrovirus Life Cycles
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Bioavailability Study Design: Healthy Subjects Versus Patients
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Subviral Agents

